SCHEMBL15966537

SCHEMBL15966537

CC(C)CON(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11560304 0.75
SCHEMBL18530850 0.75 HSD17B10 (0.36)
SCHEMBL9276264 0.73 TSHR (0.35)
SCHEMBL22024100 0.73 PIK3CD (0.36)
SCHEMBL13966613 0.71
SCHEMBL5638153 0.69
SCHEMBL22131416 0.69 MAPK1 (0.32)
SCHEMBL11030675 0.69 ALDH1A1 (0.32)
SCHEMBL24658751 0.67
SCHEMBL669347 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573978-B2 Cyclosporin derivatives for the treatment and prevention of a viral infection S&T GLOBAL, INC. (US) 2017-02-21 US disclosed
US-9504728-B2 Dosage form NEUROVIVE PHARMACEUTICAL AB (SE) 2016-11-29 US disclosed
US-9119853-B2 Sanglifehrin based compounds NEUROVIVE PHARMACEUTICAL AB (SE) 2015-09-01 US disclosed
US-20140234414-A1 Novel Dosage Form Abliva Ab (SE) 2014-08-21 US disclosed